作者单位: | The Center for the Assessment of Pharmaceutical Practices (CAPP), Department of Health Policy and Management, Boston University School of Public Health, Boston, United States of America;The Center for the Assessment of Pharmaceutical Practices (CAPP), Department of Health Policy and Management, Boston University School of Public Health, Boston, United States of America;CenseoHealth, Dallas, United States of America;Department of Biostatistics, Boston University School of Public Health, Boston, United States of America;The Center for the Assessment of Pharmaceutical Practices (CAPP), Department of Health Policy and Management, Boston University School of Public Health, Boston, United States of America
|